CN103720870B - 一种治疗心肌炎症的中药制剂及制备方法 - Google Patents
一种治疗心肌炎症的中药制剂及制备方法 Download PDFInfo
- Publication number
- CN103720870B CN103720870B CN201410013444.9A CN201410013444A CN103720870B CN 103720870 B CN103720870 B CN 103720870B CN 201410013444 A CN201410013444 A CN 201410013444A CN 103720870 B CN103720870 B CN 103720870B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- 208000009525 Myocarditis Diseases 0.000 title claims abstract description 30
- 241000222336 Ganoderma Species 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000219784 Sophora Species 0.000 claims abstract description 7
- 210000000582 Semen Anatomy 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 17
- 240000000163 Cycas revoluta Species 0.000 claims description 16
- 235000008601 Cycas revoluta Nutrition 0.000 claims description 16
- 241000390128 Eutrema Species 0.000 claims description 16
- 241001293164 Eutrema japonicum Species 0.000 claims description 16
- 235000000760 Wasabia japonica Nutrition 0.000 claims description 16
- 238000005202 decontamination Methods 0.000 claims description 12
- 230000003588 decontaminative Effects 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 241000206501 Actaea <angiosperm> Species 0.000 claims description 6
- 241000219780 Pueraria Species 0.000 claims description 6
- 241001180876 Saposhnikovia Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- -1 boil 1-2 hour Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 230000001476 alcoholic Effects 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000004570 mortar (masonry) Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 24
- 201000010099 disease Diseases 0.000 abstract description 15
- 210000002216 Heart Anatomy 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 6
- 210000004165 Myocardium Anatomy 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 4
- 230000002107 myocardial Effects 0.000 abstract description 3
- 230000002633 protecting Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 210000003462 Veins Anatomy 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 240000003291 Armoracia rusticana Species 0.000 abstract 1
- 235000011330 Armoracia rusticana Nutrition 0.000 abstract 1
- 235000016855 Biancospino Nutrition 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 241000218916 Cycas Species 0.000 abstract 1
- 229940045761 Evening primrose extract Drugs 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 240000008916 Oenothera biennis Species 0.000 abstract 1
- 235000004496 Oenothera biennis Nutrition 0.000 abstract 1
- 240000004600 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000004370 Pastinaca sativa Species 0.000 abstract 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 abstract 1
- 240000007078 Peucedanum palustre Species 0.000 abstract 1
- 235000008040 Peucedanum palustre Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 235000002313 hawthorn Nutrition 0.000 abstract 1
- 235000009444 hawthorn Nutrition 0.000 abstract 1
- 235000009486 hawthorn Nutrition 0.000 abstract 1
- 235000009682 hawthorn Nutrition 0.000 abstract 1
- 235000009685 hawthorn Nutrition 0.000 abstract 1
- 235000009917 hawthorn Nutrition 0.000 abstract 1
- 235000013161 hawthorn Nutrition 0.000 abstract 1
- 235000013165 hawthorn Nutrition 0.000 abstract 1
- 235000013189 hawthorn Nutrition 0.000 abstract 1
- 235000013204 hawthorn Nutrition 0.000 abstract 1
- 235000013214 hawthorn Nutrition 0.000 abstract 1
- 235000013246 hawthorn Nutrition 0.000 abstract 1
- 235000017423 hawthorn Nutrition 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 231100000486 side effect Toxicity 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 28
- 210000004369 Blood Anatomy 0.000 description 27
- 210000000214 Mouth Anatomy 0.000 description 16
- 230000001737 promoting Effects 0.000 description 12
- 210000004185 Liver Anatomy 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 210000004072 Lung Anatomy 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 230000001717 pathogenic Effects 0.000 description 9
- 206010007554 Cardiac failure Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 8
- 210000000952 Spleen Anatomy 0.000 description 8
- 206010019280 Heart failure Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 231100000614 Poison Toxicity 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 208000006673 Asthma Diseases 0.000 description 5
- 210000002784 Stomach Anatomy 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 210000004204 Blood Vessels Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010007625 Cardiogenic shock Diseases 0.000 description 4
- 241000668709 Dipterocarpus costatus Species 0.000 description 4
- 206010018836 Haematochezia Diseases 0.000 description 4
- 206010019233 Headache Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000001154 acute Effects 0.000 description 4
- 201000008286 diarrhea Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000000056 organs Anatomy 0.000 description 4
- 210000001015 Abdomen Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010003119 Arrhythmia Diseases 0.000 description 3
- 206010007521 Cardiac arrhythmias Diseases 0.000 description 3
- 239000003390 Chinese drug Substances 0.000 description 3
- 208000001848 Dysentery Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010062060 Hyperlipidaemia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 210000003734 Kidney Anatomy 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010037844 Rash Diseases 0.000 description 3
- 206010072736 Rheumatic disease Diseases 0.000 description 3
- 210000003932 Urinary Bladder Anatomy 0.000 description 3
- 201000000736 amenorrhea Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000000844 anti-bacterial Effects 0.000 description 3
- 230000003110 anti-inflammatory Effects 0.000 description 3
- 230000003683 cardiac damage Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000003211 malignant Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 244000052769 pathogens Species 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 210000004556 Brain Anatomy 0.000 description 2
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000001780 Epistaxis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 210000000232 Gallbladder Anatomy 0.000 description 2
- 206010018987 Haemorrhage Diseases 0.000 description 2
- 229940088597 Hormone Drugs 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 210000000936 Intestines Anatomy 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040490 Sexually transmitted disease Diseases 0.000 description 2
- 206010040872 Skin infection Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000002429 anti-coagulation Effects 0.000 description 2
- 230000000843 anti-fungal Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 231100000319 bleeding Toxicity 0.000 description 2
- 230000000740 bleeding Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003247 decreasing Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010046 dilated cardiomyopathy Diseases 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 230000003203 everyday Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000001861 immunosuppresant Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 230000000552 rheumatic Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 231100000224 toxic side effect Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010001902 Amaurosis Diseases 0.000 description 1
- 206010002156 Anal fistula Diseases 0.000 description 1
- 206010002383 Angina pectoris Diseases 0.000 description 1
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 206010003549 Asthenia Diseases 0.000 description 1
- 206010003671 Atrioventricular block Diseases 0.000 description 1
- 206010003816 Autoimmune disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000010217 Blepharitis Diseases 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 210000001736 Capillaries Anatomy 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000008787 Cardiovascular Disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 210000003169 Central Nervous System Anatomy 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008479 Chest pain Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010012118 Defect conduction intraventricular Diseases 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 210000001105 Femoral Artery Anatomy 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018913 Haemolysis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000006750 Hematuria Diseases 0.000 description 1
- 208000002287 Hemorrhoids Diseases 0.000 description 1
- 208000006572 Human Influenza Diseases 0.000 description 1
- 208000009576 Hypercholesterolemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010022000 Influenza Diseases 0.000 description 1
- 206010022437 Insomnia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010061255 Ischaemia Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 210000003141 Lower Extremity Anatomy 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000004115 Mitral Valve Anatomy 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028334 Muscle spasms Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010029410 Night sweats Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000008494 Pericarditis Diseases 0.000 description 1
- 210000003516 Pericardium Anatomy 0.000 description 1
- 210000004224 Pleura Anatomy 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N Rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000007888 Sinus Tachycardia Diseases 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000001562 Sternum Anatomy 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 206010044640 Tricuspid valve incompetence Diseases 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 231100000611 Venom Toxicity 0.000 description 1
- 210000001048 Venoms Anatomy 0.000 description 1
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 1
- 206010047461 Viral infection Diseases 0.000 description 1
- 206010047470 Viral myocarditis Diseases 0.000 description 1
- 208000001756 Virus Disease Diseases 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 210000003905 Vulva Anatomy 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000954 anitussive Effects 0.000 description 1
- 230000003266 anti-allergic Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating Effects 0.000 description 1
- 230000001139 anti-pruritic Effects 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 230000000259 anti-tumor Effects 0.000 description 1
- 230000000840 anti-viral Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000001174 ascending Effects 0.000 description 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000271 cardiovascular Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 201000001084 cerebrovascular disease Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001427 coherent Effects 0.000 description 1
- 230000000985 convulsing Effects 0.000 description 1
- 230000002920 convulsive Effects 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000916 dilatatory Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000021271 drinking Nutrition 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 230000003628 erosive Effects 0.000 description 1
- 230000001076 estrogenic Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229930003944 flavones Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002443 hepatoprotective Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002458 infectious Effects 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 201000001429 intracranial thrombosis Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 201000005505 measles Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000000422 nocturnal Effects 0.000 description 1
- 230000000050 nutritive Effects 0.000 description 1
- 201000008125 pain agnosia Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000025627 positive regulation of urine volume Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000306 recurrent Effects 0.000 description 1
- 230000002829 reduced Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000284 resting Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001502 supplementation Effects 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 200000000020 tissue injury Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing Effects 0.000 description 1
- 201000001943 tricuspid valve insufficiency Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000000261 vasodilator Effects 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000017613 viral reproduction Effects 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
Abstract
本发明涉及一种治疗心肌炎症的中药制剂及制备方法,制成所述中药制剂有效成分的原料组成为:白芍药、葛根、升麻、黄芩、桂枝、前胡、防风、莲藕、两面针、槐花、月见草、苏铁、山楂、桃仁、山葵和灵芝;本发明中药制剂所选药材配伍相宜,符合中医药和现代医药研究理论,并采用现代先进的医药制药技术制成,具有益气养元、扶正祛邪、养心通脉之功效,能够双向调节免疫功能,有效控制各种心肌炎症状,保护心肌,促进心肌功能恢复,疗效显著,不仅作用时间长,疗程短,见效快,安全无毒副作用,而且具有防止病情发生、迁延及预防复发的作用。
Description
技术领域
本发明涉及中药领域,特别涉及一种治疗心肌炎症的中药制剂及制备方法。
背景技术
心肌炎是指由各种原因引起的心肌炎症性病变。感染、物理、自身免疫性疾病和化学等因素均可引起心肌炎,但所造成的心肌损害的轻重程度差别很大,临床表现各异,轻症患者无任何症状,而重症患者可发生心力衰竭、心源性休克甚至猝死。大部分患者经治疗可获得痊愈,有些患者在急性期之后发展为扩张型心肌病改变,可反复发作最后产生心力衰竭。
心肌炎可发生于各年龄的人群,以青壮年发病较多。对于感染性原因引起的心肌炎,常先有原发感染的表现,如病毒性者常有发热、咽痛、咳嗽、呕吐、腹泻、肌肉酸痛等,大多在病毒感染1~3周后出现心肌炎的症状。心肌炎的临床症状与心肌损害的特点有关,如以心律失常为主要表现者可出现心悸、严重者可有黑蒙和晕厥;以心力衰竭为主要表现者可出现心力衰竭的各种症状如呼吸困难等;严重者发生心源性休克而出现休克的相关表现;若炎症累及心包膜及胸膜时,可出现胸闷、胸痛症状;有些患者亦可有类似心绞痛的表现,见于重症心肌炎,因心脏扩大可致二尖瓣或三尖瓣关闭不全,心尖部或胸骨左下缘收缩期杂音,心肌损害严重或心力衰竭者,可闻舒张期奔马律,第一心音减弱,合并心包炎者可闻心包摩擦音,轻者可完全无症状,可发生猝死。
对于心肌炎的治疗,目前还没有特异方法,主要是强调应卧床休息,以减轻心脏负担和组织损伤。对于心肌炎的治疗,主要是采用针灸、免疫抑制剂以及激素等,针灸主要是针对心律失常、心力衰竭、心源性休克的治疗,免疫抑制剂并没有获得一致公认的临床疗效,故不推荐常规应用,由于重症心肌炎伴有房室传导阻滞,心源性休克者等可以应用激素。
由于上述治疗的缺陷性,对于心肌炎的治疗往往得不到最好的治疗,使患者病情加重,最终延误了病情的治疗,由此我们急需一种有效的药物来帮助患者治愈心肌炎症。
发明内容
本发明提供了一种治疗心肌炎症的中药制剂及制备方法;本发明中药制剂所选药材配伍相宜,符合中医药和现代医药研究理论,并采用现代先进的医药制药技术制成,具有益气养元、扶正祛邪、养心通脉之功效,能够双向调节免疫功能,有效控制各种心肌炎症状,保护心肌,促进心肌功能恢复,疗效显著,不仅作用时间长,疗程短,见效快,安全无毒副作用,而且具有防止病情发生、迁延及预防复发的作用。
为实现上述目的,本发明的技术方案实施如下:
一种治疗心肌炎症的中药制剂,制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药45-73份 葛根45-73份 升麻45-73份 黄芩40-68份
桂枝40-68份 前胡38-65份 防风38-65份 莲藕38-65份
两面针35-58份 槐花35-58份 月见草35-58份 苏铁32-52份
山楂32-52份 桃仁28-48份 山葵28-48份 灵芝28-48份。
制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药63份 葛根63份 升麻63份 黄芩60份
桂枝60份 前胡57份 防风57份 莲藕57份
两面针51份 槐花51份 月见草51份 苏铁46份
山楂46份 桃仁43份 山葵43份 灵芝43份。
制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药59份 葛根59份 升麻59份 黄芩53份
桂枝53份 前胡51份 防风51份 莲藕51份
两面针46份 槐花46份 月见草46份 苏铁42份
山楂42份 桃仁38份 山葵38份 灵芝38份。
制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药52份 葛根52份 升麻52份 黄芩47份
桂枝47份 前胡44份 防风44份 莲藕44份
两面针40份 槐花40份 月见草40份 苏铁37份
山楂37份 桃仁33份 山葵33份 灵芝33份。
一种治疗心肌炎症的中药制剂的制备方法,包括以下工艺步骤:
(1)取白芍药、升麻、黄芩、前胡、两面针、槐花、月见草、苏铁和山楂去杂质,洗净放入容器内,加入7-9倍量的蒸馏水,浸泡3-4小时后,煮沸2-3小时,提取;再次加入4-6倍量蒸馏水,煮沸1-2小时,提取;最后加入2-3倍量蒸馏水,加热煮沸1-2小时,提取;合并三次提取液,过滤,留滤液,将滤液浓缩为60℃环境下相对密度1.15~1.25的稠膏,备用;
(2)取葛根和莲藕去杂质洗净,捣汁,取汁液备用;
(3)取桂枝、桃仁、灵芝去杂质,微波烘干,置于研钵内研末,过200目细粉,备用;
(4)取防风和山葵去杂质洗净,晾干,加入5倍量的85%乙醇溶液,浸泡2-3小时,加热提取2小时,回收乙醇,滤过,留滤液备用;
(5)将上述步骤(1)-(4)所制得的稠膏、汁液、细粉和滤液混合,利用现代先进的制药科技,制成片剂,即为所述的治疗心肌炎症的中药制剂。
本发明所用中药的药性如下:
白芍药:味酸,微寒,有小毒。通顺血脉,缓中,散恶血,逐贼血,去水气,利膀胱、大小肠。主治痈肿,时行寒热,中恶,腹痛,腰痛。《药性论》载:“臣。能治肺邪气,腹中绞痛,血气积聚,通宣脏腑拥气,治邪痛败血,主时疾骨热,强五脏,补肾气,治心腹坚胀,妇人血闭不通,消瘀血,能蚀脓。”现代医学研究证明,白芍药对人体心脑血管具有很好地保护和调养的作用,对人体中枢神经病痛有很好地治疗和抑制作用。
葛根:味甘、辛,性凉;归脾、胃经。解肌退热,生津透疹,升阳止泻。用于外感发热头痛、项背强痛,口渴,消渴,麻疹不透,热痢,泄泻,高血压颈项强痛。现代药理研究表明,葛根中提出的黄酮能增加脑及冠状血管血流量,降低血管阻力,所含的大豆黄酮具有解痉作用,还能降低血糖,并有解热及雌激素样作用,葛根素对高血压、高血脂、高血糖和心脑血管疾病有一定疗效。
升麻:味辛、甘,性微寒;归肺、脾、大肠、胃经。清热解毒,发表透疹,升阳举陷。主治时疫火毒,口疮,咽痛,斑疹,头痛寒热,痈肿疮毒,中气下陷,脾虚泄泻,久痢下重。《纲目》载:“升麻引阳明清气上行,柴胡引少阳清气上行,此乃禀赋素弱、元气虚馁及劳役饥饱、生冷内伤,脾胃引经最要药也。”现代医学研究证实,升麻提取物具有抗菌、降压、抑制心肌、减慢心率的作用,对中枢神经系统有镇静作用。
黄芩:味苦,性寒;归肺、胆、脾、胃、大肠、小肠经。清热燥湿,泻火解毒,止血安胎,降血压。主治湿温,胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,血热吐衄,痈肿疮毒。《本经》载:“主诸热黄疸,肠僻,泄利,逐水,下血闭,恶疮,疽蚀,火疡。”现代医学研究证实,黄芩有显著的抑菌、抗真菌、抗病毒、抗炎、抗变态反应等作用,能降低血压、抑制血小板聚集、抗凝、降血脂,此外还有保肝、利胆、抗氧化、抗癌功效。
桂枝:味辛、甘,性温;入膀胱、心、肺经。散寒解表,温通经脉,通阳化气。主治风寒表证,寒湿痹痛,四肢厥冷,经闭腹痛,症瘕结块,胸痹,心悸,小便不利。用于风寒感冒,脘腹冷痛,血寒经闭,关节痹痛,痰饮蓄水,水肿,心悸,奔豚。现代药理研究表明,桂枝具有发汗解肌,温经通脉,助阳化气,散寒止痛之功效。
前胡:味苦、辛,性微寒;归肺经。散风清热,降气化痰。用于风热咳嗽痰多,痰热喘满,咯痰黄稠。《日华子本草》载:“治一切劳,下一切气,止嗽,破症结,开胃下食,通五脏,主霍乱转筋,骨节烦闷,反胃,呕逆,气喘,安胎,小儿一切疳气。”
防风:味辛、甘,性微温;归膀胱、肺、脾、肝经。祛风解表,胜湿止痛,解痉止痒。主治外感风寒,头痛身痛,风湿痹痛,骨节酸痛,腹痛泄泻,肠风下血,破伤风,风疹瘙痒,疮疡初起。《日华子本草》载:“治三十六般风,男子一切劳劣,补中益神,风赤眼,止泪及瘫缓,通利五脏关脉,五劳七伤,羸损盗汗,心烦体重,能安神定志,匀气脉。”
莲藕:味甘,性凉。补中焦,养神,益气力,清热生津,凉血止血,散瘀血。《中医》载,“主补中养神,益气力”。现代医学研究证实,藕的营养价值很高,富含铁、钙等微量元素、植物蛋白质、维生素以及淀粉含量也很丰富,有明显的补益气血,增强人体免疫力作用。
两面针:味苦、辛,性平,有小毒;归肝、胃经。行气止痛,活血化瘀,祛风通络。用于气滞血瘀引起的跌打损伤、风湿痹痛,胃痛,牙痛,毒蛇咬伤;外治汤火烫伤。现代医学研究证实,两面针制成散剂,在局部治疗溃疡消除疼痛,促进愈合以及缩短疗程等各方面均收到了满意的效果,并具有抗炎、镇痛、抗肿瘤、抗真菌,调节心血管系统等方面的作用,还具有强心、降血压等药理作用。
槐花:味苦,性微寒;入肝、肺、心、大肠经。凉血止血,清肝明目。主治肠风便血,痔疮下血,血痢,尿血,血淋,崩漏,吐血,衄血,肝热头痛,目赤肿痛,痈肿疮疡。《本草正》载:“凉大肠,杀疳虫。治痈疽疮毒,阴疮湿痒,痔漏,解杨梅恶疮,下疳伏毒。”现代医学研究证实,槐花所含的芸香甙可增强毛细血管抵抗力,改善血管壁脆性,降低血压、抗水肿,对高血压有防止脑血管破裂的功效,此外还有抗炎作用。
月见草:味甘、苦,性温。现代医学研究证实,月见草可治疗多种疾病,能够调节血液中类脂物质含量,对高胆固醇、高血脂引起的冠状动脉梗塞、粥样硬化及脑血栓等症有显著疗效。
苏铁:味甘、淡,性平,有小毒。收敛止血,理气止痛,益肾固精。用于胃痛,遗精,白带,痛经。平肝,降血压。
山楂;味酸、甜,性微温;入脾、胃、肝经。有降血压,促进胃肠消化的作用。现代医学研究证实,山楂可健脾消积,山楂片泡水当茶饮,可以降血脂。
桃仁:味苦、甘,性平;归心、肝、大肠经。活血祛瘀,润肠通便,止咳平喘。主治经闭,痛经,癓瘕痞块,跌扑损伤,肠燥便秘。《本经逢原》载:“桃仁,为血瘀血闭之专药。苦以泄滞血,甘以生新血,治热入血室,瘀积症瘕,疟母,心腹痛,亦散肝经之血结。”现代医学研究证实,桃仁醇提液可增加静脉血管流量,舒张血管,能增加股动脉血流量,降低血管阻力,对血管壁有直接扩张作用,此外还有抑制血液凝固和溶血作用。
山葵:味辛,性寒;祛脂降压,解毒,调经,消食。主治风湿性疾病、高血压,高脂血症,痛经或月经不调,气喘,中鱼蟹之毒患者。
灵芝:味甘,性平;归心、肝、脾、肺、肾经。主治虚劳,咳嗽,气喘,失眠,消化不良,恶性肿瘤等。药理表明实验,灵芝对神经系统有抑制作用,对循环系统有降压和加强心脏收缩力的作用,对呼吸系统有祛痰作用,此外,还有护肝、提高免疫功能、抗菌等作用。
本发明与现有技术相比,具有以下有益效果:
1、本发明中药制剂具有益气养元、扶正祛邪、养心通脉之功效,能够双向调节免疫功能,有效控制各种心肌炎症状,保护心肌,促进心肌功能恢复,疗效显著。
2、本发明中药制剂所选药材配伍相宜,符合中医药和现代医药研究理论,并采用现代先进的医药制药技术制成,作用时间长,疗程短,见效快,安全无毒副作用,而且具有防止病情发生、迁延及预防复发的作用。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明中药制剂有效成分的原料组成及重量为:
白芍药63g 葛根63g 升麻63g 黄芩60g
桂枝60g 前胡57g 防风57g 莲藕57g
两面针51g 槐花51g 月见草51g 苏铁46g
山楂46g 桃仁43g 山葵43g 灵芝43g。
本发明中药制剂的制备方法,包括以下工艺步骤:
(1)取白芍药、升麻、黄芩、前胡、两面针、槐花、月见草、苏铁和山楂去杂质,洗净放入容器内,加入7-9倍量的蒸馏水,浸泡3-4小时后,煮沸2-3小时,提取;再次加入4-6倍量蒸馏水,煮沸1-2小时,提取;最后加入2-3倍量蒸馏水,加热煮沸1-2小时,提取;合并三次提取液,过滤,留滤液,将滤液浓缩为60℃环境下相对密度1.15~1.25的稠膏,备用;
(2)取葛根和莲藕去杂质洗净,捣汁,取汁液备用;
(3)取桂枝、桃仁、灵芝去杂质,微波烘干,置于研钵内研末,过200目细粉,备用;
(4)取防风和山葵去杂质洗净,晾干,加入5倍量的85%乙醇溶液,浸泡2-3小时,加热提取2小时,回收乙醇,滤过,留滤液备用;
(5)将上述步骤(1)-(4)所制得的稠膏、汁液、细粉和滤液混合,利用现代先进的制药科技,制成片剂,即为所述的治疗心肌炎症的中药制剂。
用法用量:口服,每次2片,每日3次,7天为一疗程,2到4个疗程即可痊愈;病情严重者遵医嘱酌增用量。
实施例2
本发明中药制剂有效成分的原料组成及重量为:
白芍药70g 葛根70g 升麻70g 黄芩67g
桂枝67g 前胡63g 防风63g 莲藕63g
两面针56g 槐花56g 月见草56g 苏铁50g
山楂50g 桃仁47g 山葵47g 灵芝47g。
本实施例中药药剂制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明中药制剂有效成分的原料组成及重量为:
白芍药59g 葛根59g 升麻59g 黄芩53g
桂枝53g 前胡51g 防风51g 莲藕51g
两面针46g 槐花46g 月见草46g 苏铁42g
山楂42g 桃仁38g 山葵38g 灵芝38g。
本实施例中药药剂制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明中药制剂有效成分的原料组成及重量为:
白芍药52g 葛根52g 升麻52g 黄芩47g
桂枝47g 前胡44g 防风44g 莲藕44g
两面针40g 槐花40g 月见草40g 苏铁37g
山楂37g 桃仁33g 山葵33g 灵芝33g。
本实施例中药药剂制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择:
作为治疗心肌炎症的中药制剂,选择心肌炎患者78例进行临床观察,病人随机分成两组,治疗组39例,其中男20例,女性19例,年龄20-60岁,平均年龄38.9岁,病程1-10年;对照组39例,其中男21例,女性18例,年龄20-60岁,平均年龄38.6岁,病程1-10年;两组患者病历基本一致,无显著差异,具有可比性,两组均按要求控制饮食。
2、治疗方法:
对于治疗组的患者服用本发明中药制剂,口服,每次2片,每日3次,7天为一疗程,连续服用2到4个疗程即可痊愈,病情严重者遵医嘱酌增用量。
对照组服用玉丹荣心丸,按说明书用,病情严重者遵医嘱酌增用量。
3、疗效判断:
治愈:发热、咽痛、咳嗽、呕吐、腹泻、肌肉酸痛等症状消失,心力衰竭、心急炎症等痊愈,身体恢复健康。
好转:上述症状有所减轻,心急炎症有所缓解。
无效:症状无变化。
4、治疗结果:
治疗组:治愈30例,好转7例,无效2例,治愈率为76.9%,总有效率为94.9%。
对照组:治愈16例,好转11例,无效12例,治愈率为41.0%,总有效率为69.2%。
以上结果显示,治疗组的治愈率和总有效率明显高于对照组。
5、典型病例举例:
(1)孔某,女,43岁,外企高管,江西井冈山人。患者于半年前开始畏寒发热,四肢乏力,伴少许咳嗽,胸闷、呼吸急促,以为是流感,对症治疗后,症状未见减轻,入院检查,发现窦性心动过速,两肺改变,心室不完全性室内传导阻滞,诊断为病毒性心肌炎伴急性肺水肿、重症肺炎。后患者开始服用本发明中药制剂,服药2个疗程后,症状好转,继续服用3个疗程,病情痊愈。
(2)徐某,女,24岁,银行职员,山西长治人。患者由于受凉后出现过性高热,患者胸闷乏力,气喘,未加重视,次日症状加重,入院心电图检查后,医生确诊为心肌炎,服用本发明中药制剂4个疗程,患者病情痊愈,随访未见复发。
(3)杨某,男,32岁,工人,甘肃平凉人。患者常感心悸,胸闷和气急,特别是劳累后明显加重,且在每天晚上睡觉时发现下肢肿胀,用手指压迫后有凹陷,恢复较慢,由于工作疲劳,经常饮酒消乏。入院检查,患者心律不齐、心率过速,心电图电轴左偏,彩超左房左室扩大,室壁运动普遍降低,EPSS增大,心脏收缩功能降低,诊断为充血型心肌病、心功能不全。经医生劝诫,患者彻底戒酒,静养休息,积极治疗,服用本发明中药制剂3个疗程后,患者病情痊愈。
(4)易某,男,46岁,农民,天津南开区人。患者经常感到胸闷无力,动态心电图提示频发室性早搏,9800次/24小时;64排螺旋CT提示心尖部心肌缺血,确诊为心肌炎。服用西药治疗后发现效果不佳,患者开始服用本发明中药制剂共4个疗程,心急炎症痊愈,随访未见复发。
Claims (5)
1.一种治疗心肌炎症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药45-73份 葛根45-73份 升麻45-73份 黄芩40-68份
桂枝40-68份 前胡38-65份 防风38-65份 莲藕38-65份
两面针35-58份 槐花35-58份 月见草35-58份 苏铁32-52份
山楂32-52份 桃仁28-48份 山葵28-48份 灵芝28-48份。
2.根据权利要求1所述的一种治疗心肌炎症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药63份 葛根63份 升麻63份 黄芩60份
桂枝60份 前胡57份 防风57份 莲藕57份
两面针51份 槐花51份 月见草51份 苏铁46份
山楂46份 桃仁43份 山葵43份 灵芝43份。
3.根据权利要求1所述的一种治疗心肌炎症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药59份 葛根59份 升麻59份 黄芩53份
桂枝53份 前胡51份 防风51份 莲藕51份
两面针46份 槐花46份 月见草46份 苏铁42份
山楂42份 桃仁38份 山葵38份 灵芝38份。
4.根据权利要求1所述的一种治疗心肌炎症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
白芍药52份 葛根52份 升麻52份 黄芩47份
桂枝47份 前胡44份 防风44份 莲藕44份
两面针40份 槐花40份 月见草40份 苏铁37份
山楂37份 桃仁33份 山葵33份 灵芝33份。
5.一种如权利要求1-4任一项所述治疗心肌炎症的中药制剂的制备方法,其特征在于:包括以下工艺步骤:
(1)取白芍药、升麻、黄芩、前胡、两面针、槐花、月见草、苏铁和山楂去杂质,洗净放入容器内,加入7-9倍量的蒸馏水,浸泡3-4小时后,煮沸2-3小时,提取;再次加入4-6倍量蒸馏水,煮沸1-2小时,提取;最后加入2-3倍量蒸馏水,加热煮沸1-2小时,提取;合并三次提取液,过滤,留滤液,将滤液浓缩为60℃环境下相对密度1.15~1.25的稠膏,备用;
(2)取葛根和莲藕去杂质洗净,捣汁,取汁液备用;
(3)取桂枝、桃仁、灵芝去杂质,微波烘干,置于研钵内研末,过200目细粉,备用;
(4)取防风和山葵去杂质洗净,晾干,加入5倍量的85%乙醇溶液,浸泡2-3小时,加热提取2小时,回收乙醇,滤过,留滤液备用;
(5)将上述步骤(1)-(4)所制得的稠膏、汁液、细粉和滤液混合,制成片剂,即为所述的治疗心肌炎症的中药制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410013444.9A CN103720870B (zh) | 2014-01-11 | 2014-01-11 | 一种治疗心肌炎症的中药制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410013444.9A CN103720870B (zh) | 2014-01-11 | 2014-01-11 | 一种治疗心肌炎症的中药制剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103720870A CN103720870A (zh) | 2014-04-16 |
CN103720870B true CN103720870B (zh) | 2015-02-25 |
Family
ID=50445332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410013444.9A Expired - Fee Related CN103720870B (zh) | 2014-01-11 | 2014-01-11 | 一种治疗心肌炎症的中药制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103720870B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106599A (zh) * | 2015-09-01 | 2015-12-02 | 江淑芬 | 一种用于治疗病毒性心肌炎的中药组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1222298C (zh) * | 2001-06-26 | 2005-10-12 | 邓大勇 | 一种治疗心血管病的药物 |
CN101433686A (zh) * | 2007-11-12 | 2009-05-20 | 贺宇 | 清脏中药 |
-
2014
- 2014-01-11 CN CN201410013444.9A patent/CN103720870B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103720870A (zh) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104873705A (zh) | 一种治疗冠心病心绞痛的药物组合物及其应用 | |
CN103610936B (zh) | 一种治疗冠心病的中药制剂及制备方法 | |
CN103285343B (zh) | 一种治疗肝癌的药物及其制备方法 | |
CN104771729A (zh) | 一种用于肺癌辅助治疗的中药丸剂及制备方法 | |
CN104306639A (zh) | 一种治疗心肌梗塞的中药制剂及制备方法 | |
CN103720870B (zh) | 一种治疗心肌炎症的中药制剂及制备方法 | |
CN105833172A (zh) | 用于治疗无症状性心肌缺血的中药冲剂及制备方法 | |
CN105816753A (zh) | 化痰止咳宁 | |
CN104666999A (zh) | 一种降血压的中药配方 | |
CN103845671B (zh) | 心力衰竭温阳益气散及制备方法 | |
CN103860990B (zh) | 冠心病活血通络散剂及制备方法 | |
CN103055271B (zh) | 一种用于治疗慢性胃炎的药物及制备方法 | |
CN103860991B (zh) | 急性心衰补气安神冲剂及制备方法 | |
CN104352750A (zh) | 一种治疗扩张型心肌病的中药冲剂及其颗粒的制备方法 | |
CN104323260B (zh) | 产科用促进泌乳的保健食品及制备方法 | |
CN103356970A (zh) | 一种治疗乳腺增生的中药组方 | |
CN105709005A (zh) | 一种乳康丸 | |
CN105797106A (zh) | 一种用于治疗心脏室性早搏的中药饮剂及制备方法 | |
CN101041051A (zh) | 一种内服治疗虚寒型菌痢的中药组合物 | |
CN105816830A (zh) | 一种用于治疗肥厚型梗阻性心肌病的中药制剂及制备方法 | |
CN103877461A (zh) | 心肌缺血温阳益气冲剂及制备方法 | |
CN105943933A (zh) | 一种用于治疗心律不齐的胶囊及制备方法 | |
CN105641654A (zh) | 一种治疗充血性心力衰竭的中药组合物 | |
CN105664025A (zh) | 一种用于治疗小儿腹胀的中药制剂及制备方法 | |
CN105688050A (zh) | 一种治疗肝炎后肝硬化门脉高压的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150225 Termination date: 20160111 |